Texas Sen. Ted Cruz and others are asking the FDA to clarify its opposition to HCQ as a Covid treatment for high-risk outpatients, and President Trump is joining in. Its widespread use in the non-Anglo world and the fact it’s cheap are arguments in its favor.
“Clearly, President Trump has not given up on the potential this drug combination may hold. Dr. Risch’s assessment is clear. For high-risk patients over 65 or with pre-existing conditions, the outpatient use of the hydroxychloroquine, zinc, and azithromycin combination has shown a significant reduction in hospitalizations and death rates.
“He asserts that we have let politics overrule science, and it is costing thousands of lives. Hopefully, senators pressuring the FDA will cause significant movement and clarity. The FDA owes its response by the end of business tomorrow. If the misinformation can be effectively cleared up, it will be a game-changer. The senators must continue to press the FDA and restore the doctor-patient relationship.”